Abstract
Learning disabilities are serious societal problems contributing to a loss of quality of life for affected individuals and their families. We hypothesized that the learning disability in Down Syndrome and perhaps in other neurodegenerative disorders is due to an imbalance between inhibitory and excitatory tone in the CNS. Specifically, we predicted that reduction of GABA related inhibition would improve learning. We used the TsDn65 mouse model of Down Syndrome and treated adult mice with daily doses of different GABA antagonists. Following treatments learning performance of these mice in several rodent learning tasks was indistinguishable from the performance of wild type mice, and the learning improvement lasted for months after the treatment ended. We are now exploring the mechanism of this durable neuroplastic effect and asking whether it would generalize to other learning disorders or optimize learning in wild type mice.
Chapter PDF
Similar content being viewed by others
Keywords
References
Fernandez, F., Morishita, W., Zuniga, E., Nguyen, J., Blank, M., Malenka, R.C., Garner, C.C.: Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat. Neurosci. 10, 411–413 (2007)
Siarey, H., Stoll, J., Rapoport, S.I., Galdzicki, Z.: Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down syndrome. Neuropharmacology 36, 1549–1554 (1997)
Costa, A.C.S., Grybko, M.J.: Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: A model of Down syndrome. Neuroscience Letters, 382-317-322 (2005)
Kleschevnikov, A.M., Belichenko, P.V., Villar, J.A.J., Epstein, C.J., Malenka, R.C., Mobley, W.C.: Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J. Neurosci. 24, 8153–8160 (2004)
Izquierdo, I., Da Cunha, C., Medina, J.H.: Endogenous benzodiazepine modulation of memory processes. Neurosci. Biobehav. Rev. 14, 419–424 (1990)
Wolfman, C., Da Cunha, C., Jerusalinsky, D., Levi de Stein, M., Viola, H., Izquierdo, I., Medina, J.H.: Habituation and inhibitory avoidance training alter brain regional levels of benzodiazepine-like molecules and are affected by intracerebral flumazenil microinjection. Brain Res. 548, 74–80 (1991)
Polc, P., Jahromi, S.S., Facciponte, G., Pelletier, M.R., Zhang, L., Carlen, P.L.: Benzodiazepine antagonist flumazenil reduces hippocampal epileptiform activity. Neuroreport 6, 1549–1552 (1995)
Hamaguchi, H., Hashimoto, T., Mori, K., Tayama, M.: Sleep in the Down syndrome. Brain Dev. 11, 399–406 (1989)
Colas, D., Valletta, J.S., Takimoto-Kimura, R., Nishino, S., Fujiki, N., Mobley, W.C., Mignot, E.: Sleep and EEG features in genetic models of Down syndrome. Neurobiology of Disease 30, 1–7 (2008)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Heller, H.C. et al. (2009). Long Term Repair of Learning Disability through Short-Term Reduction of CNS Inhibition. In: Schmorrow, D.D., Estabrooke, I.V., Grootjen, M. (eds) Foundations of Augmented Cognition. Neuroergonomics and Operational Neuroscience. FAC 2009. Lecture Notes in Computer Science(), vol 5638. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02812-0_92
Download citation
DOI: https://doi.org/10.1007/978-3-642-02812-0_92
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02811-3
Online ISBN: 978-3-642-02812-0
eBook Packages: Computer ScienceComputer Science (R0)